Retaglutide is a novel GLP-1 receptor agonist currently under research for the control of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://oisihykb253004.estate-blog.com/37895928/semaglutide-a-potential-solution-for-metabolic-disorders